Take heed to this text

The Misso robotic will assist surgeons with customized pre-planning and exact chopping for joint substitute. | Supply: Meril

Meril Life Sciences Pvt. Ltd. this week unveiled its Misso surgical robotic for simplifying orthopedic procedures.

The India-based firm introduced on LinkedIn that it’s creating surgical robotic for complete knee procedures. It mentioned it designed Misso to assist surgeons with customized pre-planning and exact chopping for joint replacements.

Misso has an optical monitoring sensor, a six-axis articulated robotic arm, and “superior” security programs, claimed Meril. The surgical robotic may help physicians carry out real-time hole checks and modify a surgical plan intraoperatively, it defined.

Varied chopping choices can be found on the Misso, together with full and partial chopping primarily based on surgeon choice. Chopping guides will not be required, and the system can carry out a tibial lower and a totally completed femur with all of the cuts, together with peg holes, in accordance with the firm.

Misso contains security options

Meril designed Misso with bone-movement monitoring to make sure security throughout procedures. If bone motion is noticed, the resection course of stops.

The resection will proceed with automated restoration of the bone place. If the robotic system’s instruments contact the affected person or different object, the collaborative robotic arm will instantly cease shifting.

Misso makes use of optical tracking-based navigation and robotic help to make sure correct leads to shaping and aligning synthetic knee joint elements. The corporate goals to enhance post-operative outcomes, cut back problems, and promote quicker affected person restoration.

Meril joins aggressive surgical robotic market

Based in 2006, Meril mentioned it’s devoted to the innovation, design, and growth of novel, clinically related gadgets. Its product portfolio contains vascular intervention gadgets, orthopedic implants, robotics, endo-surgery, ENT merchandise, and in-vitro diagnostics. 

The corporate has joined the rising surgical robotics market, the place it is going to compete with orthopedic surgical robotic builders corresponding to Stryker and Zimmer Biomet. Stryker launched its its Mako surgical robotic in 2017 and launched a joint-replacement providing in February 2024.

Additionally in February, the U.S. Meals and Drug Administration (FDA) cleared Zimmer Biomet’s Rosa surgical robotic platform for shoulder and hip substitute procedures. The FDA had cleared it for partial knee substitute for partial knee substitute in April 2021.

Editor’s be aware: This text is syndicated from The Robotic Report sibling website MassDevice.